Poland· PL-100518125
Sugammadex MSN
A sugammadex product containing sugammadexum, registered in Poland by MSN Labs Europe Limited. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sugammadex is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AB35 (sugammadex), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Sugammadex · ATC V03AB35
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Sugammadexum
- Manufacturer
- MSN Labs Europe Limited
- Country
- Poland (PL)
- ATC code
- V03AB35
- ATC class
- Sugammadex
- Defined daily dose
- 0.28 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991596460
- gtin05909991596477
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for sugammadex.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sugammadex · interactions on record
34 records
- 14 severe
- 20 moderate
Most severe, free to view
- IUP aus Plastik mit GestagenG02BA03severe
- Drospirenone and ethinylestradiolG03AA12severe
- NorethisteroneG03AC01severe
- LevonorgestrelG03AC03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sugammadex in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBLOVOVANVianex S.A., Nea Erythrea
- SpainBRIDION 100 MG/ML SOLUCION INYECTABLEMerck Sharp & Dohme B.V.
- BelgiumBridion 100 mg/mlMerck Sharp & Dohme
- SwedenBridion 100 mg/ml Injektionsvätska, lösningMerck Sharp & Dohme BV
- SwitzerlandBridion 200 mg/2 ml, InjektionslösungMSD Merck Sharp & Dohme AG
- IcelandBridionMerck Sharp & Dohme B.V.*
- NorwaySugammadex BaxterBaxter Holding B.V.
- United StatesBRIDIONMerck Sharp & Dohme LLC
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Areversin, Sugagelan
- Belgium · Sugammadex, Sugammadex Aguettant
- Bulgaria · Сугамадекс Аптафарма, Сугамадекс Ромфарм
- Cyprus · Sugammadex Accord, Sugammadex Anabiosis
- Czechia · Blovovan, Nobridex
- Germany · Areversin, Risvedex Ibi
- Denmark · Sugammadex "aguettant" Aguettant, Sugammadex "kalceks"
- Estonia · Sugammadex Accord, Sugammadex Kalceks
- Spain · Sugammadex, Sugammadex Accord
- Finland · Sugammadex Accord, Sugammadex Aguettant
- France · Sugammadex, Sugammadex Accord
- United Kingdom (Northern Ireland) · Sugammadex, Sugammadex 100 Mg/Ml Solution For Injection Wockhardt Uk
- Greece · Blovovan, Sugammadex Anabiosis
- Croatia · Areversin, Sugamadeks Accord
- Hungary · Areversin, Sugammadex Aguettant
- Ireland · Sugammadex, Sugammadex Accord Healthcare Ireland
- Iceland · Bridion, Sugammadex Amomed
- Italy · Risvedex Ibi, Sugammadex Abdi Farma
- Liechtenstein · Bridion, Sugammadex Amomed
- Lithuania · Sugammadex Accord, Sugammadex Kalceks
- Luxembourg · Sugammadex Eg, Sugammadex Eg (Eurogenerics)
- Latvia · Sugammadex Kalceks, Sugammadex Msn
- Malta · Sugammadex Anfarm, Sugammadex Aspen
- Netherlands · Sugagelan, Sugammadex
- Norway · Bridion, Sugammadex Accord
- Portugal · Sugamadex Accord, Sugamadex Aguettant
- Romania · Areversin, Sugammadex Accord
- Sweden · Sugamadex Galenicum, Sugammadex Accord
- Slovenia · Sugamadeks, Sugamadeks Aptapharma
- Slovakia · Areversin, Sugammadex Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aae9b2c3-4e15-4c30-afdf-bd43818ba063 GET /v1/drugs/aae9b2c3-4e15-4c30-afdf-bd43818ba063?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "100 mg/ml",
"packaging": "05909991596460 ¦ Rpz ¦ 165429\n10 fiol. 2 ml\n05909991596477 ¦ Rpz ¦ 165430\n10 fiol. 5 ml",
"substance": "Sugammadexum natricum 108.8 mg/ml",
"common_name": "Sugammadexum",
"pl_product_id": "100518125",
"pozwolenie_nr": "29592",
"auth_procedure": "MRP",
"authorisation_validity": "2031-03-18"
}See everything about sugammadex.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.